Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib Treatment Patterns in Chinese Patients With Mantle Cell Lymphoma
CTR20170129Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Mar 2017
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bortezomib in mantle cell lymphoma (MCL), sponsored by Janssen Pharmaceutical. Started Mar 2017; status: completed.
02
Drugs
bortezomib
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on CTR20170129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170129.